규제 업데이트

FDA, EMA, TGA 및 글로벌 규제 동향

#Ibandronate Sodium ×

규제 업데이트

2026년 9월 4일•1분 읽기

FDA Approves ANDA078948 for Ibandronate Sodium Tablet

The FDA has approved ANDA078948 for a prescription oral tablet of Ibandronate Sodium 150 mg, sponsored by Apotex and manufactured by Golden State Medical Supply.